
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia
Keywords: Tardive dyskinesia; Schizophrenia; Pharmacogenetics; Vesicular monoamine transporter 2 (VMAT2/SLC18A2); (TD); tardive dyskinesia; (VMAT2); vesicular monoamine transporter 2; (CATIE); Clinical Antipsychotic Trials of Intervention Effectiveness; (SNP); sing